Diffusion Tensor–MRI Evidence for Extra-Axonal Neuronal Degeneration in Caudate and Thalamic Nuclei of Patients with Multiple Sclerosis

References

1. 1.↵
   1. Charcot J

   . Histologie de la sclérose en plaques [in French]. Gas Hop (Paris) 1868;141:554–58
2. 2.↵
   1. Dawson JW

   . The histology of multiple sclerosis. Trans R Soc (Edinb) 1916;50:517–740
3. 3.↵
   1. Brownell B,
   2. Hughes JT

   . The distribution of plaques in the cerebrum in multiple sclerosis. J Neurol Neurosurg Psychiatry 1962;25:315–20

   FREE Full Text
4. 4.↵
   1. Kidd D,
   2. Barkoff F,
   3. McConnell R,
   4. et al

   . Cortical lesions in multiple sclerosis. Brain 1999;122 (Pt1): 17–26

   Abstract/FREE Full Text
5. 5.↵
   1. Miller DH,
   2. Barkhof F,
   3. Frank JA,
   4. et al

   . Measurement of atrophy in multiple sclerosis; pathological basis, methodological aspects and clinical relevance. Brain 2002;125:1676–95

   Abstract/FREE Full Text
6. 6.↵
   1. Zivadinov R,
   2. Cox JL

   . Neuroimaging in multiple sclerosis. Int Rev Neurobiol 2007;79:449–74

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Mesaros S,
   2. Rocca MA,
   3. Absinta M,
   4. et al

   . Evidence of thalamic grey matter loss in pediatric multiple sclerosis. Neurology 2008;70:1107–12

   Abstract/FREE Full Text
8. 8.↵
   1. Tao G,
   2. Datta S,
   3. He R,
   4. et al

   . Deep grey matter atrophy in multiple sclerosis: A tensor based morphometry. J Neurol Sci 2009;282:39–46

   CrossRefPubMedWeb of Science
9. 9.↵
   1. Sepulcre J,
   2. Sastre-Garriga J,
   3. Cercignani M,
   4. et al

   . Regional grey matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Arch Neurol 2006;63:1175–80

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Audoin B,
    2. Davies GR,
    3. Finisku L,
    4. et al

    . Localization of grey matter atrophy in early RRMS: a longitudinal study. J Neurol 2006;253:1495–501

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Bermel RA,
    2. Bakshi R

    . The measurement and clinical relevance of brain atrophy in multiple sclerosis. Lancet Neurol 2006;5:158–70

    CrossRefPubMedWeb of Science
12. 12.↵
    1. Khaleeli Z,
    2. Cercignani M,
    3. Audoin B,
    4. et al

    . Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage 2007;37:253–61

    CrossRefPubMedWeb of Science
13. 13.↵
    1. Rovaris M,
    2. Gass A,
    3. Bammer R,
    4. et al

    . Diffusion MRI in multiple sclerosis. Neurology 2005;65:1526–32

    Abstract/FREE Full Text
14. 14.↵
    1. Ge Y,
    2. Law M,
    3. Grossman RI

    . Applications of diffusion tensor MR imaging in multiple sclerosis. Ann N Y Acad Sci 2005;1064:202–19

    CrossRefPubMedWeb of Science
15. 15.↵
    1. Hasan KM,
    2. Halphen C,
    3. Kamali A,
    4. et al

    . Caudate nuclei volume, diffusion tensor metrics, and T(2) relaxation in healthy adults and relapsing-remitting multiple sclerosis patients: implications for understanding grey matter degeneration. J Magn Reson Imaging 2009;29:70–77

    CrossRefPubMedWeb of Science
16. 16.↵
    1. Tovar-Moll F,
    2. Evangelou IE,
    3. Chiu AW,
    4. et al

    . Thalamic involvement and its impact on clinical disability in patients with multiple sclerosis: a diffusion tensor imaging study at 3T. AJNR Am J Neuroradiol 2009;30:1380–86

    Abstract/FREE Full Text
17. 17.↵
    1. McDonald WI,
    2. Compston A,
    3. Edan G,
    4. et al

    . Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001;50:121–27

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Fischl B,
    2. Salat DH,
    3. Busa E,
    4. et al

    . Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain. Neuron 2002;33:341–55

    CrossRefPubMedWeb of Science
19. 19.↵
    1. Fischl B,
    2. Salat DH,
    3. van der Kouwe AJ,
    4. et al

    . Sequence-independent segmentation of magnetic resonance images. Neuroimage 2004;23:S69–84

    CrossRefPubMedWeb of Science
20. 20.↵
    1. Smith SM,
    2. Jenkinson M,
    3. Woolrich MW,
    4. et al

    . Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 2004;23:208–19

    CrossRef
21. 21.↵
    1. Smith SM

    . Fast robust automated brain extraction. Hum Brain Mapp 2002;17:143–55

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Souplet JC

    . Évaluation de l'atrophie et de la charge lésionnelle sur des séquences IRM de patients atteints de sclérose en plaques [in French]. PhD thesis, Université de Nice Sophia-Antipolis 2009
23. 23.↵
    1. Hasan KM,
    2. Halphen C,
    3. Boska MD,
    4. et al

    . Diffusion tensor metrics, T2 relaxation, and volumetry of the natural aging human caudate nuclei in healthy young and middle-aged adults: possible implications for the neurobiology of human brain aging and disease. Magn Reson Med 2008;59:7–13

    CrossRefPubMedWeb of Science
24. 24.↵
    1. Hasbani MJ,
    2. Schlief ML,
    3. Fisher DA,
    4. et al

    . Dendritic spines lost during glutamate receptor activation reemerge at original sites of synaptic contact. J Neurosci 2001;21:2393–403

    Abstract/FREE Full Text
25. 25.↵
    1. Trapp BD,
    2. Wujek JR,
    3. Criste GA,
    4. et al

    . Evidence for synaptic stripping by cortical microglia. Glia 2007;55:360–68

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Kim IJ,
    2. Beck HN,
    3. Lein PJ,
    4. et al

    . Interferon gamma induces retrograde dendritic retraction and inhibits synapse formation. J Neurosci 2002;22:4530–39

    Abstract/FREE Full Text
27. 27.↵
    1. Mori S,
    2. Itoh R,
    3. Zhang J,
    4. et al

    . Diffusion tensor imaging of the developing mouse brain. Magn Reson Med 2001;46:18–23

    CrossRefPubMedWeb of Science
28. 28.↵
    1. Mukherjee P,
    2. Miller JH,
    3. Shimony JS,
    4. et al

    . Diffusion-tensor MR imaging of gray and white matter development during normal human brain maturation. AJNR Am J Neuroradiol 2002;23:1445–56

    Abstract/FREE Full Text
29. 29.↵
    1. Zhang J,
    2. Richards LJ,
    3. Yarowsky P,
    4. et al

    . Three-dimensional anatomical characterization of the developing mouse brain by diffusion tensor microimaging. Neuroimage 2003;20:1639–48

    CrossRefPubMedWeb of Science
30. 30.↵
    1. Assaf Y,
    2. Basser PJ

    . Composite hindered and restricted model of diffusion (CHARMED) MR imaging of the human brain. Neuroimage 2005;27:48–58

    CrossRefPubMedWeb of Science
31. 31.↵
    1. Vinken P,
    2. Bruyn G

    1. Lumsden C

    . The neuropathology of multiple sclerosis. In: Vinken P, Bruyn G . Handbook of Clinical Neurology. Volume 9. Multiple Sclerosis and Other Demyelinating Diseases. New York: American Elsevier; 1970: 217–309
32. 32.↵
    1. Wheeler-Kingshott C,
    2. Cercignani M

    . About “axial” and “radial” diffusivities. Magn Reson Med 2009;61:1255–60

    CrossRefPubMedWeb of Science
33. 33.↵
    1. Jones DK,
    2. Cercignani M

    . Twenty-five pitfalls in the analysis of diffusion MRI data. NMR Biomed 2010;23:803–20

    CrossRefPubMedWeb of Science
34. 34.↵
    1. Pierpaoli C,
    2. Basser PJ

    . Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med 1996;36:893–906

    CrossRefPubMedWeb of Science